2)
As regards the pain item, it was assessed whether (-) or (+).
3) As regards the redness item, it was assessed whether (-) or (+). 4) As regards the swelling item, it was assessed whether (-) or (+). All the subjects were placed under observation for 5 days from the operation and the presence or absence of postoperative pains were directly inquired of them the day following the operation. X statistical method was adopted for the calculation of significant differences of the data obtained.
Classification of the teeth extracted
The teeth extracted of the subjects were arranged in the followffing threecategories.
a. Simple extractions 25 (Carnosine group) 25 (Placebo group) b. Bone scaling 9 (Carnosine group) 1 (Placebo group) c. Root fraction 9 (Carnosine group) 1 (Placebo group) When the subjects were further classified in terms of the manifestation ofan acute inflammation, it was absent in 64 (carnosine 38; placebo 26) and waspresent in 12 (carnosine 5; placebo 7).
Clinical Findings
For the convenience of presenting data obtained from the above clinical tests, they are summarized in a tabular form below (Table 2) . 
Discussion
As is shown by Table 2 , an application of carnosine in the form of dental cones (5mg per cone) proved quite effective in inhibiting extractive inflammatory effects, as manifested in the postoperative pain, swelling and redness.
As the amount of carnosine which works to interfere with bradykinine established by NAGAI et al. is 100-300mg/Kg, that contained in one dental cone corresponds to 500mg%-1000mg% in concentration on the basis that the volume of 5mg to 10mg carnosine is postulated at 1 ml. Therefore, one dental cone is considered as being sufficiently potent and, as in the present clinical test, the antiinflammatory action of carnosine is also helped by its anti-bradykinine effect.
A local pain which occurs as a result of an inflammation is regarded as being caused by a pain producing substance (P.P.S.) physiologically. For this reason, a local anti-pain agent such as carnosine has effects that i) it promotes the decomposition of P.P.S. in the localized area, ii) it interferes with the production of P.P.S., iii) it promotes an elimination of P.P.S. through the blood stream, and iv) it disrupts the chemical reaction between a chemical mediator working in favor of repairing the inflamed tissues and P.P.S. It is assumed that all these effects combine themselves in bringing the inflamed tissues back to normalcy and, consequently, alleviation of pains associated with them.
This antiinflammatory action of carnosine can be schematically represented, as in Fig. 1 below. This kind of horizontal effect, as it were, is not seen on the part of various antiinflammatory drugs hitherto in use.
Conclusions
1. An application of carnosine in the form of dental cone (5mg per cone) proved highly successful in eliminating pains associated with the extraction of teeth.
2. This action of carnosine is to be sought in inhibiting the production of a pain producing substance (P.P.S.).
